RPTX

Repare Therapeutics INC

+$18.4M

Net Activity

Institutions Holding

47

Popularity Rank

#6083

Avg Weight

0.16%

Total Value

$66.6M

Ownership Trend

47 institutions currently hold RPTX, with 22 net buyers and 19 net sellers this quarter.

Institutional Moves

Institutional Moves (Q4 2025)

Neutral

Based on recent trading activity

Net Selling Institutions

19

Net Buying Institutions

22

Key Holders

View all 47 holding institutions

Quarterly Activity

Recent Activity

+$15.4M

Total Buy Value

$9.0M

Total Sell Value

New buy13
Trim8
Add9
Sold out11

22

Net Buyers

19

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding REPARE THERAPEUTICS INC (RPTX)?
Major stakeholders currently include Bvf Inc/il ($26.9M), Blue Owl Capital Holdings LP ($9.0M), Orbimed Advisors LLC ($8.6M). Based on the latest 13F filings, there are a total of 47 tracked investment funds and institutions maintaining positions in RPTX.
What is the overall institutional sentiment toward RPTX recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $18.4M, driven by 22 managers accumulating shares while 19 reduced their exposure.
Which institutions have been selling or reducing their RPTX positions?
In the latest period, 8 funds trimmed their holdings, and 11 managers completely exited their positions. The aggregate reported sell value was $9.0M.
Are there any notable investors adding RPTX to their portfolios?
Yes, buying activity remains notable. 13 institutions opened new positions in {ticker}, and 9 existing holders added to their shares. The total reported buy value for the quarter amounted to $15.4M.

Related Stocks